Rockford, IL, September 23, 2026 —

PCI Pharma Services has announced the opening of three new facilities in Rockford, Illinois. This expansion marks a significant step in the company’s global operational growth.

The newly established facilities are designed to increase the company’s capacity for packaging medicines. This development is a component of a larger, ongoing global investment by PCI Pharma Services, which amounts to approximately one billion dollars.

The expansion is also expected to generate substantial employment opportunities in the region. Approximately 650 skilled jobs are anticipated to be created as a direct result of these new operations in Rockford.

Further details regarding the specific timelines for job creation, the precise nature of the packaging capacity, or the exact allocation of the billion-dollar global investment were not provided in the summary. The company’s specific plans for utilizing the new facilities to meet market demands remain to be detailed.

PCI Pharma Services is a global contract development and manufacturing organization (CDMO) that provides a comprehensive range of integrated services. The company’s services span drug substance to final drug product, including the sterile drug product manufacturing, analytical services, and clinical trial services.

The investment in Rockford underscores the company’s commitment to expanding its footprint and capabilities to support the pharmaceutical industry’s evolving needs. The strategic location and increased capacity aim to enhance the company’s ability to serve its clients effectively.



Story summarized from the original created by Samantha Soto on www.rockfordnewsfirst.com, see more information here.

Media gallery

About The Author